ICP
BSX icon

Ilex Capital Partners’s Boston Scientific BSX Stock Holding History

Ilex Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,234,180
Closed -$140M – 151
2026
Q1 		$140M Buy
2,234,180
+633,379
+40% +$50.7M 3.45% 7
2025
Q4 		$153M Buy
+1,600,801
New +$157M 4.31% 6

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ilex Capital Partners's BSX Position: Q2 2026 in Review

Ilex Capital Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 2,234,180 shares — an estimated $140M sold.

Ilex Capital Partners first reported a position in BSX in Q4 2025 and held it in 2 quarters. The position peaked at $153M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ilex Capital Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Ilex Capital Partners sold 2,234,180 Boston Scientific shares in Q2 2026, an estimated $140M.
  • Ilex Capital Partners first reported a position in Boston Scientific in Q4 2025 and held it in 2 quarters.
  • Ilex Capital Partners's Boston Scientific position peaked at $153M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ilex Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.